This is a research study for an investigational medication being developed for infections caused by the bacterium Acinetobacter baumannii. This is the first time this study drug will be given to humans.
• Healthy Non-smoking males and females of non-childbearing potential, Age 18-64
• BMI (body mass index) 18-32
• Join us for a stay of 6 nights and 2 follow up visits
• Compensation up to $3,296 for time and participation